January/February 2018

Feature

From the Field

Mock Clinical Pathways: Exploring the Process of Developing a Pathway for Metastatic Breast Cancer

02/15/2018

Bruce A Feinberg, DO

Chadi Nabhan, MD, MBA, FACP

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care delivery, allowing for cost reduction as well as more predictable, measurable, and accountable outcomes. At the 2nd Annual...

Abstract: Clinical...

02/15/2018

Journal of Clinical Pathways

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Casey Mason

Peter G Ellis, MD

Kathy Lokay

Amanda Barry, MPH

Natalie Dickson, MD

Ray Page, DO, PhD

Blase Polite, MD

Ravi Salgia, MD, PhD

Michael Savin, MD

Corey Shamah, MD

Mark A Socinski, MD

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways

Column

Pharma Insights

How Variations in Health Systems Influence Oncology Practices

02/15/2018

Ashwin Athri, MBA

Changing marketplace dynamics related to the demographics and economics of cancer care is making it necessary for health systems to adapt and invest in capabilities ranging from care coordination models to a...

...

02/15/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Who Really Controls Treatment Selection? It`s Not Always Who You Think

02/15/2018

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

New policies and legislation related to health care reform mean that control over treatment selections may also shift within different markets. For professionals creating a clinical pathway for a disease state, it is...

New...

02/15/2018

Journal of Clinical Pathways

Editor's Page

Utilizing Pathways Among Shifting Market Dynamics

02/15/2018

Winston Wong, PharmD, Editor-in-Chief

As the health care system collectively progresses toward full adoption of the Medicare Access and CHIP reauthorization Act, providers, practices, and health systems have been working to understand the full impact of...

As the...

02/15/2018

Journal of Clinical Pathways

Department

How Christiana Care and Strata Precision Oncology Are Making No-Cost Tumor Profiling and DNA Sequencing More Accessible

02/15/2018

JCP Editors

Researchers in cancer care have made great strides in recent years. Contributing to these advancements is the new ability to sequence tumors from cancer patients in order to determine specific gene mutations...

...

02/15/2018

Journal of Clinical Pathways

News

Conference Coverage

American Society of Clinical Oncology Gastrointestinal Cancer Symposium

02/15/2018

JCP Editors

The American Society of Clinical Oncology (ASCO) hosted its annual Gastrointestinal (GI) Cancers Symposium in San Francisco, California, from January 18-20, 2018. The GI Cancers Symposium is a specialized oncology...

The...

02/15/2018

Journal of Clinical Pathways

Department

Research in Review

Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine

02/15/2018

JCP Editors

Real-World Outcomes of Patients With NSCLC Treated With PD-1 Inhibitors After Approval Certain subgroups of patients with NSCLC are underrepresented in clinical trials for newly approved PD-1 inhibitors...

...

02/15/2018

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

January/February 2018

Feature

Column

News

Department

Current Issue

Special Reports

Subscribe

Volume 4

Specialties

Events

Year Round Education

HMP Global Products